JAMA oncology

ISSN: 2374-2437

Journal Home

Journal Guideline

JAMA oncology Q1 Unclaimed

American Medical Association United States
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

JAMA oncology is a journal indexed in SJR in Medicine (miscellaneous) with an H index of 127. It has a price of 4598 €. It has an SJR impact factor of 7,502 and it has a best quartile of Q1. It has an SJR impact factor of 7,502.

JAMA oncology focuses its scope in these topics and keywords: cancer, breast, response, years, outcomes, paclitaxel, recurrence, colorectal, digital, complete, ...

Type: Journal

Type of Copyright:

Languages:

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: weekly

Scopus WOS
Categories: Cancer Research (Q1) Oncology (Q1)
Price

4598 €

Inmediate OA

0 €

Embargoed OA

0 €

Non OA

Metrics

JAMA oncology

7,502

SJR Impact factor

127

H Index

425

Total Docs (Last Year)

1338

Total Docs (3 years)

6513

Total Refs

12909

Total Cites (3 years)

544

Citable Docs (3 years)

9.35

Cites/Doc (2 years)

15.32

Ref/Doc

Comments

No comments ... Be the first to comment!

Aims and Scope


cancer, breast, response, years, outcomes, paclitaxel, recurrence, colorectal, digital, complete, testing, metastatic, pathologic, cancervalidation, careracialethnic, childhood, candesartan, cancersuggestibility, cancerincorrect, cancerglobal, canceranalysis, bonetargeted, blockadecomplementary, bevacizumab, benefit, alternative, affordable,

FAQS